1. Home
  2. EVGN vs MCVT Comparison

EVGN vs MCVT Comparison

Compare EVGN & MCVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EVGN
  • MCVT
  • Stock Information
  • Founded
  • EVGN 1999
  • MCVT 2007
  • Country
  • EVGN Israel
  • MCVT United States
  • Employees
  • EVGN N/A
  • MCVT N/A
  • Industry
  • EVGN Agricultural Chemicals
  • MCVT Finance Companies
  • Sector
  • EVGN Industrials
  • MCVT Finance
  • Exchange
  • EVGN Nasdaq
  • MCVT Nasdaq
  • Market Cap
  • EVGN 11.3M
  • MCVT 11.1M
  • IPO Year
  • EVGN N/A
  • MCVT N/A
  • Fundamental
  • Price
  • EVGN $1.37
  • MCVT $1.92
  • Analyst Decision
  • EVGN Strong Buy
  • MCVT
  • Analyst Count
  • EVGN 1
  • MCVT 0
  • Target Price
  • EVGN $3.50
  • MCVT N/A
  • AVG Volume (30 Days)
  • EVGN 273.7K
  • MCVT 19.1K
  • Earning Date
  • EVGN 08-21-2025
  • MCVT 08-13-2025
  • Dividend Yield
  • EVGN N/A
  • MCVT N/A
  • EPS Growth
  • EVGN N/A
  • MCVT N/A
  • EPS
  • EVGN N/A
  • MCVT 0.19
  • Revenue
  • EVGN $6,765,000.00
  • MCVT $3,246,479.00
  • Revenue This Year
  • EVGN N/A
  • MCVT N/A
  • Revenue Next Year
  • EVGN $113.18
  • MCVT N/A
  • P/E Ratio
  • EVGN N/A
  • MCVT $9.92
  • Revenue Growth
  • EVGN N/A
  • MCVT N/A
  • 52 Week Low
  • EVGN $0.95
  • MCVT $1.13
  • 52 Week High
  • EVGN $6.80
  • MCVT $3.88
  • Technical
  • Relative Strength Index (RSI)
  • EVGN 50.23
  • MCVT 57.00
  • Support Level
  • EVGN $1.32
  • MCVT $1.78
  • Resistance Level
  • EVGN $1.50
  • MCVT $1.96
  • Average True Range (ATR)
  • EVGN 0.08
  • MCVT 0.08
  • MACD
  • EVGN -0.00
  • MCVT 0.00
  • Stochastic Oscillator
  • EVGN 45.83
  • MCVT 78.95

About EVGN Evogene Ltd

Evogene Ltd is a computational biology company targeting to revolutionize product development for life-science based industries, including human health, agriculture, and industrial applications. The company established its technology, the Computational Predictive Biology (CPB) platform. The CPB platform is designed to computationally discover and develop life-science products based on microbes, small molecules, and genetic elements as the core components for such products. It holds several subsidiaries utilizing the CPB platform for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits, and ag-solutions for castor oil production. It generates maximum revenue from the Agriculture segment, followed by Industry.

About MCVT Mill City Ventures III Ltd.

Mill City Ventures III Ltd is a non-bank lender and specialty finance company. The company is engaged in the business of providing short-term specialty finance solutions to private businesses, micro-and small-cap public companies, and high-net-worth individuals. The principal specialty finance solutions that the group provides are high-interest short-term lending arrangements. Typically, these lending arrangements involve obtaining collateral as security for the borrower's repayment of funds, or personal guarantees from the principals or affiliates of the borrower.

Share on Social Networks: